Clinical Development Strategy Advisor
Associated with :
Rushford Business SchoolDr. Bradley Joblin is a clinical development specialist with 20 years of experience in early-phase study design and clinical development strategy. He has held senior roles at AstraZeneca and Roche, managing global Phase III/IV studies. As the founder of Armstrong Clinical, he provides strategic guidance to biotech and pharmaceutical companies across various therapeutic areas, including neurology, oncology, autoimmune diseases, respiratory disorders, dermatology, and infectious diseases. Dr. Joblin is passionate about integrating modern evidence generation practices to enhance clinical development efficiency and accelerate the delivery of innovative therapies to patients.